EXPLORING THE IMPACT OF PILLBOX USABILITY ON ADHERENCE AND GLYCEMIC REGULATION IN PRIMARY CARE SETTING WITH TYPE 2 DIABETES MELLITUS SYOFYAN

SYOFYAN SYOFYAN; NINDYA VIONA ASFIQRA; NAJMIATUL FITRIA

doi:10.22159/ajpcr.2025v18i10.55891

Authors

SYOFYAN SYOFYAN Department of Pharmaceuticals, Faculty of Pharmacy, Universitas Andalas, Padang, Indonesia.
NINDYA VIONA ASFIQRA Bachelor Program, Faculty of Pharmacy, Universitas Andalas, Padang, Indonesia.
NAJMIATUL FITRIA Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Andalas, Padang, Indonesia. https://orcid.org/0000-0002-3255-1961

DOI:

https://doi.org/10.22159/ajpcr.2025v18i10.55891

Keywords:

usability, pillbox, type 2 diabetes mellitus, adherence, random blood glucose

Abstract

Objectives: Type 2 diabetes mellitus (T2DM) needs continuing adherence and effective self-management strategies to achieve optimal glycemic control. This investigation sought to explore the link between pillbox usability and patient adherence, patient adherence, and random blood glucose (RBG) levels, in addition to pillbox usability and RBG levels in T2DM.

Methods: This observational study involved 33 patients with T2DM receiving care from the Lubuk Kilangan Primary Health Center, selected through purposive sampling. Pillbox usability was assessed using the System Usability Scale questionnaire, medication adherence was measured over a monthly period using the pill count method, and RBG data were obtained from patients’ clinical records. Data were analyzed using Spearman’s rank correlation test to consider relationships between variables.

Results: The findings indicated no significant correlation between pillbox usability and either medication adherence or RBG levels (p>0.05). However, a significant negative link existed between medication adherence and RBG levels, with moderate strength (r=−0.456; P=0.008).

Conclusion: These findings point to improved medication adherence contributing to better glycemic control, as indicated by lower RBG levels. Nevertheless, pillbox usability was not found to have a significant impact on either adherence or blood glucose control.

Downloads

Download data is not yet available.

References

1. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018 Feb;14(2):88-98. doi: 10.1038/nrendo.2017.151, PMID 29219149

2. Sękowski K, Grudziąż-Sękowska J, Pinkas J, Jankowski M. Public knowledge and awareness of diabetes mellitus, its risk factors, complications, and prevention methods among adults in Poland - A 2022 nationwide cross-sectional survey. Front Public Health. 2022;10:1029358. doi: 10.3389/fpubh.2022.1029358, PMID 36620244

3. Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275. doi: 10.3390/ijms21176275, PMID 32872570

4. International Diabetes Federation. International Diabetic Federation Diabetic Atlas. 10th ed., Vol. 102. Netherlands: International Diabetes Federation (IDF); 2021.

5. Yosmar R, Shepany E, Fitria N. A comprehensive analysis of antidiabetic drug interactions in geriatric non-insulin dependent diabetes mellitus patients. Int J Appl Pharm. 2024;16(1):62-5.

6. Fitria N, Andela M, Rerita R, Nasif H. Cost-effectiveness of metformin-glimepiride combination compared to single metformin use in decreasing 2 h post prandial blood glucose. Int J Appl Pharm. 2024;16(1):53-7. doi: 10.22159/ijap.2024.v16s1.10

7. Sari YO, Fitria N, Mariza W, Lailiani R, Permatasari D. Application of home medication review (HMR) on patient adherence in type 2 diabetes mellitus (T2DM) blood sugar management. J Sains Farm Klin. 2022;9(suppl):160-7.

8. Fitria N, Idrus L, Putri AR, Sari YO. The usability testing of the integrated electronic healthcare services for diabetes mellitus patients during the pandemic in Indonesia. Digit Health. 2023;9:20552076231173228. doi: 10.1177/20552076231173227, PMID 37152237

9. National Institute of Health Research and Development. Laporan Provinsi Sumatera Barat Riskesdas. Jakarta: Kemenkes RI; 2018. p. 2019. Available from: https://repository.badankebijakan.kemkes. go.id/id/eprint/3906

10. Fitria N, Husnia K, Ananta FT, Sari YO. The effect of pillbox use in increasing patients’ adherence to type 2 diabetes mellitus therapy in Lubuk Kilangan health center. Pharm Pract (Granada). 2023;21(4):1-5. doi: 10.18549/PharmPract.2023.4.2904

11. Mathews AS. Intervention of clinical pharmacist in the management of type 2 diabetes mellitus in outpatients. Int J Pharm Pharm Sci. 2021;13(10):31-4. doi: 10.22159/ijpps.2021v13i10.42435

12. Andanalusia M, Nita Y, Athiyah U. The effect of pillbox use and education by pharmacist toward medication adherence in diabetes mellitus patients in a Primary Health Care Center in Mataram. J Basic Clin Physiol Pharmacol. 2021 Jun;32(4):577-82. doi: 10.1515/ jbcpp-2020-0500, PMID 34214347

13. Chandrappa S, Shetty S, Narayana A, Rajarathnna K. A comparative study of efficacy and safety of glimepiride versus gliclazide as an add on to metformin in type 2 diabetes mellitus at a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2024;14:1. doi: 10.5455/ njppp.2024.14.03142202430032024

14. Indonesian Society of Endocrinology, Adi SS, Indonesian Society of Endocrinology. In: Soelistijo S, editor. Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia. 1st ed. Global Initiative for Asthma. Jakarta: PB Perkeni; 2021. p. 1-119.

15. Febriyanti AP, Tahar N, Badriani B, Dhuha NS, Wahyudin M, Khaerani K, et al. A comparative study to enhance medication adherence: Pillbox vs medication reminder chart. Planar. 2021;1:26. doi: 10.18860/planar.v1i0.1456

16. Fitria N, Lailaturrahmi L, Sari YO, Anata FT, Husnia K. Adherence assessment on hypertension therapy using the pill count method in lubuk Kilangan Health Center, Indonesia. J Sains Farm Klin. 2023;10(1):69-75. doi: 10.25077/jsfk.10.1.28-34.2023

17. Rattanapiratanon A, Kongsomboon K, Hanprasertpong T. Efficacy of a 28-compartment pillbox for improving iron supplement compliance in healthy pregnant women: A randomised controlled trial. J Obstet Gynaecol. 2021 Nov;41(8):1210-5. doi: 10.1080/01443615.2020.1856056, PMID 33645407

18. Lewis JR, Sauro J. Item benchmarks for the system usability scale. J Usability Stud. 2018;13(3):158-67.

19. Fivi Melva D, Najmiatul F. Association of omega 3 and omega 6 and child development: A systematic review. Nutr Clin Diet Hosp. 2022;42(2):98-104.

20. Fitria N, Amalia SP, Machlaurin A, Nasif H. The role of iron folic acid and multiple micronutrients in type of childbirth delivery: Economic and health implication. Asian J Pharm Clin Res. 2025;18(2):43-8.

21. Noetzli LJ, Mittelman SD, Watanabe RM, Coates TD, Wood JC. Pancreatic iron and glucose dysregulation in thalassemia major. Am J Hematol. 2012 Feb;87(2):155-60. doi: 10.1002/ajh.22223, PMID 22120775

22. Harry O, Crosby LE, Mara C, Ting TV, Huggins JL, Modi AC. Feasibility and acceptability of an innovative adherence intervention for young adults with childhood-onset systemic lupus erythematosus. Pediatr Rheumatol Online J. 2020 Apr;18(1):36. doi: 10.1186/s12969- 020-00430-z, PMID 32340616

23. Santos HF, Guaraldo L, Pedro RS, Damasceno LS, Daniel- Ribeiro CT, Brasil P. Methods to assess adult and adolescent patients’ adherence to antimalarial treatment: A systematic review. Front Pharmacol. 2022;13:796027. doi: 10.3389/fphar.2022.796027, PMID 35571076

24. Kassahun T, Eshetie T, Gesesew H. Factors associated with glycemic control among adult patients with type 2 diabetes mellitus: A cross-sectional survey in Ethiopia. BMC Res Notes. 2016;9(1):78. doi: 10.1186/s13104-016-1896-7, PMID 26861243

25. Mozaffarian D. Dietary and policy prioritites for CVD, diabetes and obesity - a comprehensive review. Circulation. 2016;133(2):187-225. doi: 10.1161/CIRCULATIONAHA.115.018585, PMID 26746178